...
首页> 外文期刊>Annals of nuclear medicine >Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: A comparison of ablation success with different activities of radioiodine (I-131)
【24h】

Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: A comparison of ablation success with different activities of radioiodine (I-131)

机译:分化型甲状腺癌局限于甲状腺的患者的辅助甲状腺残余消融:不同放射性碘活动的消融成功率比较(I-131)

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To assess efficiency of various I-131 activities on thyroid remnant ablation in thyroid cancer patients. The significance of patients' characteristics, pathologic features and levels of Tg were analyzed. Patients and methods This study included 259 consecutive differentiated thyroid cancer patients, with disease confined to the thyroid, treated with I-131 after total thyroidectomy. Patients were divided into the three groups: 80 patients receiving low [1110-1850 MBq (30-50 mCi)], 121 intermediate [2775 MBq (75 mCi)] and 58 high [3700 MBq (100 mCi)] postoperative I-131 activities. Six to eight months after the application of radioiodine, measurements of TSH, Tg, anti-Tg antibodies (in hypothyroid state) together with ultrasound exam and whole-body scintigraphy were performed. Results The ablation was significantly more effective (after the first application) in patients receiving 100 mCi of I-131-89.7 % than in patients receiving lower activities (P = 0.016). There was no significant difference in ablation rate between the 30-50 mCi (77.5 %) and 75 mCi (70.2 %) groups. In the group receiving 30-50 mCi, patients with solitary tumors had significantly higher ablation rate (P = 0.038). In patients receiving 75 mCi ablation rates were higher among older patients (P = 0.005), with infiltration of the single lobe (P = 0.005), and with solitary tumor (P = 0.012). The rates of successful ablation after the second application of I-131 (after 12-16 months) amounted to 96, 97 and 96 % in the 30-50, 75 and 100 mCi groups, respectively. The activity of I-131 and age were independent factors for thyroid ablation failure after the first application of I-131 (model of binary logistic regression). Conclusion The results of remnant ablation were satisfactory with all activities applied. Although after the first application of I-131 the activity of 100 mCi is significantly more effective in thyroid ablation than the administration of 30-50 mCi and 75 mCi, the ablation rates between all the three groups are similar (almost equal) after the second application. Thus, the activity to be administered may depend on patients' characteristics and a detailed consideration of the merits and demerits of each I-131 activity.
机译:目的评估各种I-131活性对甲状腺癌患者甲状腺残余消融的疗效。分析了患者特征,病理特征和Tg水平的意义。患者和方法本研究包括259例连续分化的甲状腺癌患者,其疾病仅限于甲状腺,在全甲状腺切除术后用I-131治疗。患者分为三组:80例术后I-131接受低剂量[1110-1850 MBq(30-50 mCi)],121例中度[2775 MBq(75 mCi)]和58例高剂量[3700 MBq(100 mCi)]。活动。应用放射性碘后六到八个月,对TSH,Tg,抗Tg抗体(甲状腺功能减退),超声检查和全身闪烁显像进行测量。结果接受100 mCi I-131-89.7%的患者(首次应用后)的消融效果明显优于接受较低活动的患者(P = 0.016)。 30-50 mCi(77.5%)和75 mCi(70.2%)组之间的消融率没有显着差异。在接受30-50 mCi的组中,孤立性肿瘤患者的消融率明显更高(P = 0.038)。在老年患者中,接受75 mCi消融的患者较高(P = 0.005),单叶浸润(P = 0.005)和孤立性肿瘤(P = 0.012)。在30-50、75和100 mCi组中,第二次I-131施用(12-16个月后)的成功消融率分别为96%,97%和96%。 I-131的活性和年龄是首次应用I-131(二进制逻辑回归模型)后甲状腺消融失败的独立因素。结论在进行所有活动后残余消融的结果均令人满意。尽管在首次应用I-131之后,100 mCi的活性在甲状腺消融方面比30-50 mCi和75 mCi的给药显着更有效,但三组之间的消融率在第二次相似后几乎相同(几乎相等)应用。因此,要给予的活性可能取决于患者的特征以及每种I-131活性的优缺点的详细考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号